Evidence map›Paper›PMID 42310735›Full record

ArticleJournal of translational medicine2026

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Franziska E Müller, Frauke S Bahr, Sergej Erschow, Martina Kasten, Maren Heimerl, Nils Benen, Mira Jung, Arne Schmidt, Michaela Scherr, Christine S Falk and 7 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Franziska E Müller *Institute of Neurophysiology, Cellular Neurophysiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-0525-0714
Frauke S Bahr *Institute of Neurophysiology, Cellular Neurophysiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-6417-0103
Sergej ErschowDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.ORCID 0009-0004-9586-0202
Martina KastenDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Maren HeimerlDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Nils BenenInstitute of Neurophysiology, Cellular Neurophysiology, Hannover Medical School, Hannover, Germany.
Mira JungInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Arne SchmidtInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Michaela ScherrDepartment of Hematology, Hemostaseology, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany.
Christine S FalkInstitute of Transplant Immunology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-1376-7318
Christian BustamanteNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, California, USA.ORCID 0000-0002-2275-4263
Igor PonomarevDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.ORCID 0009-0002-7253-4821
Johann BauersachsDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-9341-117X
Denise Hilfiker-KleinerDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-6065-9649
Thomas ThumInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4360-1511
Evgeni G Ponimaskin *Institute of Neurophysiology, Cellular Neurophysiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-4570-5130
Melanie Ricke-Hoch *Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. hoch.melanie@mh-hannover.de.ORCID 0000-0001-5479-2275

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial infarction (MI) is among the leading causes of death worldwide, and a precisely regulated inflammatory response is essential for effective cardiac repair and long-term outcome. The serotonergic system regulates immune cell functions, yet its contribution to post-MI remodeling is incompletely understood.

methodsHere, we investigated the role of serotonin receptor 7 (5-HT7R) in post-infarction inflammation and outcome after permanent left anterior coronary artery ligation in mice, and complementary analysis of peripheral blood mononuclear cells (PBMCs) obtained from patients with acute MI.

resultsThree days after MI, 5-HT7R mRNA expression was significantly upregulated in the infarct region compared to remote myocardium and sham operated mice. RNA-sequencing of isolated murine CD11b

conclusionsThese data suggest 5-HT7R as a regulator of post-MI immune responses and a potential target to improve repair and survival.

Indexed as

InflammationMyocardial InfarctionReceptors, SerotoninSignal TransductionAnimalsHumansLeukocytes, MononuclearMacrophagesMaleMice, Inbred C57BLMice, KnockoutMyocardiumRNA, MessengerSurvival AnalysisReceptors, SerotoninRNA, Messengerserotonin 7 receptor5-HT7RInflammationMacrophageMyocardial infarctionSerotonin

Identifiers

PMID42310735
PMCPMC13281426

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.